ARTICLE

FindCenter AddIcon

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

By Andrew R. Gallimore and Rick J. Strassman — 2016

Using pharmacokinetic modeling and DMT blood sampling data, we demonstrate that the unique pharmacological characteristics of DMT, which also include a rapid onset and lack of acute tolerance to its subjective effects, make it amenable to administration by target-controlled intravenous infusion.

Read on www.frontiersin.org

FindCenter Post-Image

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...

FindCenter AddIcon
FindCenter Post-Image

What Psychedelic Mushrooms Are Teaching Us About Human Consciousness

Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.

FindCenter AddIcon

EXPLORE TOPIC

DMT